320 likes | 430 Vues
In a pivotal ruling by the United States District Court for the District of Columbia, the plaintiffs are considered likely to succeed in their claims against the defendants for violations of the Administrative Procedure Act. The court found that the defendants acted contrary to law and in an arbitrary and capricious manner while establishing the Average Manufacturers Price. This decision underscores significant concerns regarding regulatory compliance and the administrative processes behind price determinations in the healthcare industry.
E N D